Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Tromp

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Journal of the American Heart Association|October 20, 2021
Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection FractionWan Ting Tay, Tiew-Hwa Katherine Teng, Oliver Simon, et al.
JACC. Asia|December 15, 2022
Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection FractionAbhinav Sharma, Carolyn S P Lam, Wan Ting Tay, et al.
European Journal of Heart Failure|June 7, 2023
Trajectories of renal biomarkers and new-onset heart failure in the general population: Findings from the PREVEND studyRyoto Sakaniwa, Jasper Tromp, Koen W Streng, et al.
Circulation|October 15, 2019
Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionJasper Tromp, Camilla Hage, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|January 6, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failureDaan Ceelen, Adriaan A Voors, Jasper Tromp, et al.
European Journal of Heart Failure|October 5, 2022
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF studyAshwin Venkateshvaran, Ulrika Ljung Faxen, Camilla Hage, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
Nature Communications|February 6, 2025
Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failureQing-Wen Ren, Tiew-Hwa Katherine Teng, Wouter Ouwerkerk, et al.
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF RegistryKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
Circulation. Genomic and Precision Medicine|May 16, 2023
Clinical Outcome in <i>KLHL24</i> CardiomyopathyMathilde C S C Vermeer, Karla F Arevalo Gomez, Martijn F Hoes, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Journal of the American Heart Association|October 20, 2021
Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection FractionWan Ting Tay, Tiew-Hwa Katherine Teng, Oliver Simon, et al.
JACC. Asia|December 15, 2022
Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection FractionAbhinav Sharma, Carolyn S P Lam, Wan Ting Tay, et al.
European Journal of Heart Failure|June 7, 2023
Trajectories of renal biomarkers and new-onset heart failure in the general population: Findings from the PREVEND studyRyoto Sakaniwa, Jasper Tromp, Koen W Streng, et al.
Circulation|October 15, 2019
Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionJasper Tromp, Camilla Hage, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|January 6, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failureDaan Ceelen, Adriaan A Voors, Jasper Tromp, et al.
European Journal of Heart Failure|October 5, 2022
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF studyAshwin Venkateshvaran, Ulrika Ljung Faxen, Camilla Hage, et al.
Journal of the American College of Cardiology|September 2, 2025
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-AnalysisBart J van Essen, Daan C H Ceelen, Wouter Ouwerkerk, et al.
Nature Communications|February 6, 2025
Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failureQing-Wen Ren, Tiew-Hwa Katherine Teng, Wouter Ouwerkerk, et al.
Circulation. Cardiovascular Quality and Outcomes|December 9, 2022
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF RegistryKanako Teramoto, Wan Ting Tay, Jasper Tromp, et al.
Circulation. Genomic and Precision Medicine|May 16, 2023
Clinical Outcome in <i>KLHL24</i> CardiomyopathyMathilde C S C Vermeer, Karla F Arevalo Gomez, Martijn F Hoes, et al.
Pageof 20